浆细胞瘤转化迁移基因1在肿瘤中的研究进展

摘要/Abstract

摘要： 浆细胞瘤转化迁移基因（PVT1）是一个重要的长非编码RNA，在人类基因组PVT1定位于染色体8q24.21。PVT1的异常表达和多态性与人类多种肿瘤如恶性淋巴瘤、乳腺癌、结直肠癌、胰腺癌等密切相关，并能影响肿瘤患者的生存和预后。目前认为其作用机制可能是通过与Myc基因、微小RNA或其他蛋白的相互作用，以及基因多态性等，但还不明确，对PVT1的深入研究有望为肿瘤的诊断治疗提供新靶点。

关键词: 肿瘤, 浆细胞瘤转化迁移基因1

Abstract: Plasmacytoma variant translocation1（PVT1） is a very important long nocoding RNA, which located at chromosome 8q24.21 in human beings. Aberrant expression and polymorphism of PVT1 was closely associated with various kinds of cancers such as malignant lymphoma, breast cancer, colorectal cancer, pancreatic cancer, and affected survival and prognosis of cancer patients. This mainly attribute to its interactin with myc, miRNAs and other proteins, and also gene polymorphism. Further study of PVT1 is expected to provide a new target for the diagnosis and treatment of cancer.

Key words: Neoplasms, Plasmacytoma variant translocation 1

彭娟菲, 张世能. 浆细胞瘤转化迁移基因1在肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2016, 43(2): 141-.

PENG Juan-Fei, ZHANG Shi-Neng. Plasmacytoma variant translocation 1 in cancer[J]. Journal of International Oncology, 2016, 43(2): 141-.

参考文献

［1］ Fatica A, Bozzoni I. Long noncoding RNAs: new players in cell differentiation and development［J］. Nat Rev Genet, 2014, 15(1): 721. DOI:10.1038/nrg3606. ［2］ Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future［J］. Genetics, 2013, 193(3): 651669. DOI:10.1534/genetics.112.146704. ［3］ Qiu MT, Hu JW, Yin R, et al. Long noncoding RNA: an emerging paradigm of cancer research［J］. Tumor Biol, 2013, 34(2): 613620. DOI:1007/s1327701306586. ［4］ Guan Y, Kuo WL, Stilwell JL, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer［J］. Clin Cancer Res, 2007, 13(19): 57455755. DOI:10.1158/10780432.CCR062882. ［5］ Yang YR, Zang SZ, Zhong CL, et al. Increased expression of the lncRNA PVT1 promotes tumorigenesis in nonsmall cell lung cancer［J］. Int J Clin Exp Pathol, 2014, 7(10): 69296935. ［6］ Ding J, Li D, Gong M, et al. Expression and clinical significance of the long noncoding RNA PVT1 in human gastric cancer［J］. OncoTargets Ther, 2014, 7: 16251630. DOI:10.2147/OTT.S68854. ［7］ Takahashi Y, Sawada G, Kurashige J, et al. Amplification of PVT1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers［J］. Br J Cancer, 2014, 110(1): 164171. DOI:10.1038/bjc.2013.698. ［8］ Cory S, Graham M, Webb E, et al. Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the cmyc oncogene［J］. EMBO J, 1985, 4(3): 675681. ［9］ Shtivelman E, Bishop JM. The PVT gene frequently amplifies with MYC in tumor cells［J］. Mol Cell Biol, 1989, 9(3): 11481154. ［10］ Sen R, Ghosal S, Das S, et al. Competing endogenous RNA: the key to posttranscriptional regulation［J］. Sci World J, 2014, 2014: 896206. DOI:10.1155/2014/896206. ［11］ Tseng YY, Moriarity BS, Gong W, et al. PVT1 dependence in cancer with MYC copynumber increase［J］. Nature, 2014, 512(7512): 8286. DOI:10.1038/nature13311. ［12］ Barsotti AM, Beckerman R, Laptenko O, et al. p53dependent Induction of PVT1 and miR1204［J］. J Biol Chem， 2012, 287(4): 25092519. DOI:10.1074/jbc.M111.322875. ［13］ Paci P, Colombo T, Farina L. Computational analysis identifies a sponge interaction network between long noncoding RNAs and messenger RNAs in human breast cancer［J］. BMC Syst Biol, 2014, 8: 83. DOI:10.1186/17520509883. ［14］ EncisoMora V, Broderick P, Ma Y, et al. A genomewide association study of Hodgkin′s lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)［J］. Nat Genet, 2010, 42(12): 11261130. DOI:10.1038/ng.696. ［15］ Cerhan JR, Berndt SI, Vijai J, et al. Genomewide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma［J］. Nat Genet, 2014, 46(11): 12331238. DOI:10.1038/ng.3105. ［16］ Skibola CF, Berndt SI, Vijai J, et al. Genomewide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region［J］. Am J Hum Genet, 2014, 95(4): 462471. DOI:10.1016/j.ajhg.2014.09.004. ［17］ Meyer KB, Maia A, O′Reilly M, et al. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression［J］. PLoS Genet, 2011, 7(7): e1002165. DOI:10.1371/journal.pgen.1002165. ［18］ Zhang Z, Zhu Z, Zhang B, et al. Frequent mutation of rs13281615 and its association with PVT1 expression and cell proliferation in breast cancer［J］. J Genet Genomics, 2014, 41(4): 187195. DOI:10.1016/j.jgg.2014.03.006. ［19］ Wang F, Yuan JH, Wang SB, et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem celllike property of hepatocellular carcinoma cells by stabilizing NOP2［J］. Hepatology, 2014, 60(4): 12781290. DOI:10.1002/hep.27239. ［20］ Liu E, Liu Z, Zhou Y. Carboplatindocetaxelinduced activity against ovarian cancer is dependent on upregulated lncRNA PVT1［J］. Int J Clin Exp Pathol, 2015, 8(4): 38033810. ［21］ Zhang XW, Bu P, Liu L, et al. Overexpression of long noncoding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance［J］. Biochem Biophys Res Commun, 2015, 462(3): 227232. DOI:10.1016/j.bbrc.2015.04.121. ［22］ Kong R, Zhang EB, Yin DD, et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16［J］. Mol Cancer, 2015, 14: 82. DOI:10.1186/s1294301503558. ［23］ Cao WJ, Wu HL, He BS, et al. Analysis of long noncoding RNA expression profiles in gastric cancer［J］. World J Gastroenterol, 2013, 19(23): 36583664. DOI:10.3748/wjg.v19.i23.3658. ［24］ Ding C, Yang Z, Lv Z, et al. Long noncoding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients［J］. Oncol Lett, 2015, 9(2): 955963. DOI:10.3892/ol.2014.2730. ［25］ You L, Chang D, Du HZ, et al. Genomewide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells［J］. Biochem Biophys Res Commun, 2011, 407(1): 16. DOI:10.1016/j.bbrc.2011.02.027. ［26］ Iwakawa R, Takenaka M, Kohno T, et al. Genomewide identification of genes with amplification and/or fusion in small cell lung cancer［J］. Genes Chromosomes Cancer, 2013, 52(9): 802816. ［27］ Riquelme E, Suraokar MB, Rodriguez J, et al. Frequent coamplification and cooperation between CMYC and PVT1 oncogenes promote malignant pleural mesothelioma［J］. J Thorac Oncol, 2014, 9(7): 9981007. DOI:10.1097/JTO.0000000000000202. ［28］ Nagoshi H, Taki T, Hanamura I, et al. Frequent PVT1 rearrangement and novel chimeric genes PVT1NBEA and PVT1WWOX occur in multiple myeloma with 8q24 abnormality［J］. Cancer Res, 2012, 72(19): 49544962. DOI:10.1158/00085472.CAN120213. ［29］ Macchia G, Lonoce A, Venuto S, et al. A rare but recurrent t(8;13)(q24;q14) translocation in Bcell chronic lymphocytic leukaemia causing MYC upregulation and concomitant loss of PVT1, miR15/16 and DLEU7［J］. Br J Haematol, 2015, In press. DOI:10.1111/bjh.13482.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.